Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:57 PM
Ignite Modification Date:
2025-12-24 @ 9:57 PM
NCT ID:
NCT00416832
Eligibility Criteria:
DISEASE CHARACTERISTICS:
* Diagnosis of classic Hodgkin's lymphoma (HL)
* Intermediate or advanced disease, including the following stages:
* Stage I
* Stage IIA, IIB, IIE, or IIBE
* Stage IIIA or IIIBE
* Stage IV
PATIENT CHARACTERISTICS:
* No other concurrent malignancies
* No severe concurrent diseases (e.g., immune deficiency syndrome)
PRIOR CONCURRENT THERAPY:
* No prior chemotherapy or radiotherapy
* Pre-phase therapy for large mediastinal tumor allowed
Healthy Volunteers:
False
Sex:
ALL
Maximum Age:
17 Years
Study:
NCT00416832
Study Brief:
Protocol Section:
NCT00416832